4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0000950170-24-138693
President & CEO sold 132,030 shares at an average $1.00 ($131,650)
From the SEC's structured data for this filing
Trades in this filing
ROBIN HOWARD W · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-17 | Sale : show line 1 in the form | −46,995 | $1.01 | $47,465 | 1,195,710 | D |
| 2024-12-18 | Sale : show line 2 in the form | −85,035 | $0.99 | $84,185 | 1,110,675 | D |
| Open-market sales · 132,030 sh · avg $1.00 · $131,650 | ||||||
Loading xslF345X05/ownership.xml…